Annual report pursuant to Section 13 and 15(d)

Note 5 - Financing Arrangements

v3.21.1
Note 5 - Financing Arrangements
12 Months Ended
Mar. 28, 2021
Notes to Financial Statements  
Debt Disclosure [Text Block]
Note
5
- Financing Arrangements
 
Factoring Agreements:
To reduce its exposure to credit losses, the Company assigns the majority of its trade accounts receivable to CIT pursuant to factoring agreements, which have expiration dates that are coterminous with that of the financing agreement described below. Under the terms of the factoring agreements, CIT remits customer payments to the Company as such payments are received by CIT.
 
CIT bears credit losses with respect to assigned accounts receivable from approved shipments, while the Company bears the responsibility for adjustments from customers related to returns, allowances, claims and discounts. CIT
may
at any time terminate or limit its approval of shipments to a particular customer. If such a termination or limitation occurs, the Company either assumes (and
may
seek to mitigate) the credit risk for shipments to the customer after the date of such termination or limitation or discontinues shipments to the customer. Factoring fees, which are included in marketing and administrative expenses in the accompanying consolidated statements of income, were
$291,000
and
$255,000
during fiscal years
2021
and
2020,
respectively. There were
no
advances on the factoring agreements at
March 28, 2021
or
March 29, 2020.
 
Credit Facility:
The Company's credit facility at
March 28, 2021
consisted of a revolving line of credit under a financing agreement with CIT of up to
$26.0
million, which includes a
$1.5
million sub-limit for letters of credit, bearing interest at the rate of prime minus
0.5%
or LIBOR plus
1.75%,
and which is secured by a
first
lien on all assets of the Company. On
May 13, 2021,
the Company and CIT entered into an agreement whereby CIT's lien on Carousel's assets will be automatically released upon the sale of such assets.
 
The financing agreement was scheduled to mature on
July 11, 2022,
but on
May 31, 2021
the financing agreement was amended to extend the maturity date to
July 11, 2025
and to change the interest rates to prime minus
1.0%
or LIBOR plus
1.5%,
effective as of
May 31, 2021.
The financing agreement was also amended to provide for a transition from the LIBOR reference rate to its replacement at the appropriate time. As of
March 28, 2021,
the Company had elected to pay interest on balances owed under the revolving line of credit under the LIBOR option, which was
1.87%
as of
March 28, 2021.
The financing agreement also provides for the payment by CIT to the Company of interest on daily negative balances, if any, held by CIT at the rate of prime as of the beginning of the calendar month minus
2.0%,
which was
1.25%
as of
March 28, 2021.
 
As of
March 28, 2021,
there was
no
balance owed on the revolving line of credit, there was
no
letter of credit outstanding and
$26.0
million was available under the revolving line of credit based on the Company's eligible accounts receivable and inventory balances. As of
March 29, 2020,
there was a balance of
$2.6
million owed on the revolving line of credit, there was
no
letter of credit outstanding and
$20.1
million was available under the revolving line of credit based on the Company's eligible accounts receivable and inventory balances.
 
The financing agreement contains usual and customary covenants for agreements of that type, including limitations on other indebtedness, liens, transfers of assets, investments and acquisitions, merger or consolidation transactions, transactions with affiliates, and changes in or amendments to the organizational documents for the Company and its subsidiaries. The Company believes it was in compliance with these covenants as of
March 28, 2021.
 
Paycheck Protection Program Loan:
On
April 19, 2020,
the Company executed a Note (the “Note”) in connection with a loan (the “Loan”) made pursuant to the Paycheck Protection Program (the “PPP”), which is administered by the U.S. Small Business Administration (the “SBA”) under the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) and the Paycheck Protection Program Flexibility Act of
2020
(the “Flexibility Act”). The Note was entered into with CIT Bank, N.A. (the “Lender”) for the principal amount of
$1,963,800
and bears interest at
1.0%
per year.
 
As authorized by the provisions of the CARES Act, the Company was permitted to apply to the Lender for forgiveness of all or a portion of the Loan in an amount equal to the sum of certain allowable costs incurred by the Company during the
8
-week period (extended to the
24
-week period by the Flexibility Act) beginning on
April 20, 2020,
which was the funding date of the Loan. The Note would have matured on
April 20, 2022,
but on
May 20, 2021,
the PPP Loan was forgiven in full and the SBA remitted to the Lender on that date the principal amount of the Note of
$1,963,800
and interest of approximately
$22,000
that had accrued from the funding date of
April 20, 2020
through the forgiveness date of
May 20, 2021.
 
Because the Note was forgiven during the fiscal year ending
April 3, 2022,
it has been classified a current liability in the accompanying consolidated balance sheet as of
March 28, 2021.
During the
three
-month period ending
June 27, 2021
and the fiscal year ending
April 3, 2022,
the Company anticipates that it will recognize a gain from the extinguishment of the full amount of the PPP Loan.